More Scientific Research Validates Clinical Effect of 2RT

19 May 2015

Ellex Medical Lasers Limited (ASX:ELX), today announced additional scientific research validating the method of action of the Company’s proprietary Retinal Rejuvenation Therapy (2RT™) in the treatment of early age-related macular degeneration (AMD).


Read more...

2RT™ Makes Headline in Peer-Review Publication

5 February 2015

Ellex Medical Lasers Limited announced that its proprietary 2RT™ (Retinal Rejuvenation Therapy) has been featured on the cover of the February 2015 edition of the Journal of the Federation of American Societies for Experimental Biology (FASEB Journal).


Read more...

Ellex announces further positive clinical and scientific results for 2RT treatment of early AMD

15 May 2014

Ellex today announced the 24-month follow up of the pilot study to investigate the efficacy of the Company’s proprietary Retinal Rejuvenation Therapy (2RT™) in the treatment of early Age-Related Macular Degeneration (AMD) has been released and published in a summary form at the recent Association for Research in Vision and Ophthalmology (ARVO) 2014 conference in Orlando, Florida.


Read more...

Ellex Secures CE Mark for 2RT in Treatment of Early Stage Age-Related Macular Degeneration (AMD)

26 February 2014

Ellex Medical Lasers Limited (ASX:ELX), a pioneer in medical technologies for the diagnosis and treatment of eye disease, today announced that it has secured a CE Mark (Conformité Européenne) for its proprietary Retinal Rejuvenation Therapy (2RT™) laser treatment of early Age-Related Macular Degeneration (AMD).


Read more...

Ellex Secures Ce Mark For Breakthrough Retinal Rejuvenation Therapy

18 July 2012

Ellex today announced that it has secured a CE Mark (European Conformity) for its breakthrough Retinal Rejuvenation Therapy (Ellex 2RT™). This world-first nano-pulse retinal laser therapy ushers in a new era of pain-free and damage-free retinal treatment.


Read more...

Positive Ellex 2Rt Data Demonstrates Efficacy In Treatment Of Early Amd

3 May 2011

Ellex today announced milestone clinical results for its breakthrough Retinal Regeneration Therapy (Ellex 2RT) for the treatment of Early Age-Related Macular Degeneration (AMD).


Read more...

Ellex To Preview New Laser For Treatment Of Amd

17 November 2010

Ellex today announced that it will preview a prototype of its new Retinal Regeneration Therapy (Ellex 2RT™) laser at the upcoming Royal Australian and New Zealand College of Ophthalmology (RANZCO) meeting in Adelaide, Australia, from Sunday 21 November.


Read more...

Ellex 2Rt Studies Demonstrate Clinical Efficacy In Treatment Of Age-Related Macular Degeneration And Diabetic Retinopathy

7 May 2010

Ellex announced today major positive clinical results for its world leading laser Retina Regeneration Therapy (Ellex 2RT™) for the treatment of Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR), two conditions that usually result in irreversible blindness for sufferers.


Read more...

Ellex To Present New Clinical Results For Ellex 2Rt At Arvo 2010

3 May 2010

Ellex announced today that initial clinical results of two new studies for Ellex Retina Regeneration Therapy (Ellex 2RT™) will be presented at the Association for Research in Vision and Ophthalmology’s (ARVO) 2010 Annual Meeting, which takes place 2-6 May in Fort Lauderdale.


Read more...

Ellex Secures Sublicence Agreement For Ellex 2Rt

12 April 2010

Ellex announced today that it has sublicensed Patent No. 5,549,596, effectively enabling the Company to bring Ellex 2RT™ technology to market in the US.


Read more...

Ellex 2Rt Research Program Awarded Government Grant

13 November 2009

Ellex announced today that the Ellex 2RT™ Research Program has been awarded a $0.54 million Victorian Government grant.


Read more...

Ellex Announces Six-Month Results On Retina Regeneration Therapy

10 November 2008

Ellex today announced the six-month clinical study results for the groundbreaking treatment Retina Regeneration Therapy (Ellex 2RT™).


Read more...

Ellex 2Rt Study Demonstrates Clinical Efficacy In Treatment Of Diabetic Macular Edema

10 November 2007

Ellex today announced clinical results of an ongoing study for non-thermal Retina Regeneration Therapy (Ellex 2RT™).


Read more...

Ellex Announces New Retina Regeneration Therapy To Be Presented At The AAO

1 November 2007

Ellex today announced that the initial results of treating patients with Retina Regeneration Therapy (Ellex 2RT™) will be presented by Peter Hamilton MD, FRCOph at the annual meeting of the American Academy of Ophthalmology.


Read more...